☰

John Prensner - Publications

Affiliations: 
Dana-Farber Cancer Institute, Boston, MA, United States 
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Hofman DA, Ruiz-Orera J, Yannuzzi I, Murugesan R, Brown A, Clauser KR, Condurat AL, van Dinter JT, Engels SAG, Goodale A, van der Lugt J, Abid T, Wang L, Zhou KN, Vogelzang J, ... ... Prensner JR, et al. Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. Molecular Cell. PMID 38176414 DOI: 10.1016/j.molcel.2023.12.003  0.566
2023 Koschmann C, Al-Holou WN, Alonso MM, Anastas J, Bandopadhayay P, Barron T, Becher O, Cartaxo R, Castro MG, Chung C, Clausen M, Dang D, Doherty R, Duchatel R, Dun M, ... ... Prensner JR, et al. A road map for the treatment of pediatric diffuse midline glioma. Cancer Cell. PMID 38039965 DOI: 10.1016/j.ccell.2023.11.002  0.425
2023 Hosono Y, Niknafs YS, Prensner JR, Iyer MK, Dhanasekaran SM, Mehra R, Pitchiaya S, Tien J, Escara-Wilke J, Poliakov A, Chu SC, Saleh S, Sankar K, Su F, Guo S, et al. Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA. Cell. 186: 4254-4255. PMID 37714137 DOI: 10.1016/j.cell.2023.08.025  0.331
2023 Posner Z, Yannuzzi I, Prensner JR. Shining a Light on the Dark Proteome: Non-Canonical Open Reading Frames and their Encoded MiniProteins as a New Frontier in Cancer Biology. Protein Science : a Publication of the Protein Society. e4708. PMID 37350227 DOI: 10.1002/pro.4708  0.454
2023 Hofman DA, Ruiz-Orera J, Yannuzzi I, Murugesan R, Brown A, Clauser KR, Condurat AL, van Dinter JT, Engels SAG, Goodale A, van der Lugt J, Abid T, Wang L, Zhou KN, Vogelzang J, ... ... Prensner JR, et al. Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. Biorxiv : the Preprint Server For Biology. PMID 37205492 DOI: 10.1101/2023.05.04.539399  0.586
2021 Prensner JR, Enache OM, Luria V, Krug K, Clauser KR, Dempster JM, Karger A, Wang L, Stumbraite K, Wang VM, Botta G, Lyons NJ, Goodale A, Kalani Z, Fritchman B, et al. Noncanonical open reading frames encode functional proteins essential for cancer cell survival. Nature Biotechnology. PMID 33510483 DOI: 10.1038/s41587-020-00806-2  0.402
2017 Hosono Y, Niknafs YS, Prensner JR, Iyer MK, Dhanasekaran SM, Mehra R, Pitchiaya S, Tien J, Escara-Wilke J, Poliakov A, Chu SC, Saleh S, Sankar K, Su F, Guo S, et al. Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA. Cell. 171: 1559-1572.e20. PMID 29245011 DOI: 10.1016/J.Cell.2017.11.040  0.407
2016 Niknafs YS, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, Prensner JR, Poliakov A, Singhal U, Xiao L, Kregel S, et al. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. Nature Communications. 7: 12791. PMID 27666543 DOI: 10.1038/Ncomms12791  0.355
2016 Guo H, Ahmed M, Zhang F, Yao CQ, Li S, Liang Y, Hua J, Soares F, Sun Y, Langstein J, Li Y, Poon C, Bailey SD, Desai K, Fei T, ... ... Prensner JR, et al. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. Nature Genetics. PMID 27526323 DOI: 10.1038/Ng.3637  0.331
2015 Mody RJ, Wu YM, Lonigro RJ, Cao X, Roychowdhury S, Vats P, Frank KM, Prensner JR, Asangani I, Palanisamy N, Dillman JR, Rabah RM, Kunju LP, Everett J, Raymond VM, et al. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. Jama. 314: 913-25. PMID 26325560 DOI: 10.1001/Jama.2015.10080  0.356
2015 Balbin OA, Malik R, Dhanasekaran SM, Prensner JR, Cao X, Wu YM, Robinson D, Wang R, Chen G, Beer DG, Nesvizhskii AI, Chinnaiyan AM. The landscape of antisense gene expression in human cancers. Genome Research. 25: 1068-79. PMID 26063736 DOI: 10.1101/Gr.180596.114  0.451
2015 Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A, Cao X, Dhanasekaran SM, Wu YM, Robinson DR, et al. The landscape of long noncoding RNAs in the human transcriptome. Nature Genetics. 47: 199-208. PMID 25599403 DOI: 10.1038/ng.3192  0.356
2014 Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, et al. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. The Lancet. Oncology. 15: 1469-80. PMID 25456366 DOI: 10.1016/S1470-2045(14)71113-1  0.303
2014 Prensner JR, Chen W, Han S, Iyer MK, Cao Q, Kothari V, Evans JR, Knudsen KE, Paulsen MT, Ljungman M, Lawrence TS, Chinnaiyan AM, Feng FY. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia (New York, N.Y.). 16: 900-8. PMID 25425964 DOI: 10.1016/J.Neo.2014.09.001  0.403
2014 Malik R, Patel L, Prensner JR, Shi Y, Iyer MK, Subramaniyan S, Carley A, Niknafs YS, Sahu A, Han S, Ma T, Liu M, Asangani IA, Jing X, Cao X, et al. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Molecular Cancer Research : McR. 12: 1081-7. PMID 25030374 DOI: 10.1158/1541-7786.MCR-14-0257  0.314
2014 Prensner JR, Sahu A, Iyer MK, Malik R, Chandler B, Asangani IA, Poliakov A, Vergara IA, Alshalalfa M, Jenkins RB, Davicioni E, Feng FY, Chinnaiyan AM. The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget. 5: 1434-8. PMID 24727738 DOI: 10.18632/Oncotarget.1846  0.35
2014 Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, Sahu A, Malik R, Wilder-Romans K, Navone N, Logothetis CJ, Araujo JC, Pisters LL, Tewari AK, Canman CE, et al. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Research. 74: 1651-60. PMID 24473064 DOI: 10.1158/0008-5472.Can-13-3159  0.404
2013 Balbin OA, Prensner JR, Sahu A, Yocum A, Shankar S, Malik R, Fermin D, Dhanasekaran SM, Chandler B, Thomas D, Beer DG, Cao X, Nesvizhskii AI, Chinnaiyan AM. Reconstructing targetable pathways in lung cancer by integrating diverse omics data. Nature Communications. 4: 2617. PMID 24135919 DOI: 10.1038/Ncomms3617  0.36
2013 Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, Jenkins RB, Triche TJ, Malik R, Bedenis R, McGregor N, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nature Genetics. 45: 1392-8. PMID 24076601 DOI: 10.1038/Ng.2771  0.373
2012 Prensner JR, Chinnaiyan AM, Srivastava S. Systematic, evidence-based discovery of biomarkers at the NCI. Clinical & Experimental Metastasis. 29: 645-52. PMID 22868876 DOI: 10.1007/s10585-012-9507-z  0.322
2012 Kalyana-Sundaram S, Kumar-Sinha C, Shankar S, Robinson DR, Wu YM, Cao X, Asangani IA, Kothari V, Prensner JR, Lonigro RJ, Iyer MK, Barrette T, Shanmugam A, Dhanasekaran SM, Palanisamy N, et al. Expressed pseudogenes in the transcriptional landscape of human cancers. Cell. 149: 1622-34. PMID 22726445 DOI: 10.1016/j.cell.2012.04.041  0.404
2012 Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, ... ... Prensner JR, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 487: 239-43. PMID 22722839 DOI: 10.1038/Nature11125  0.316
2012 Prensner JR, Rubin MA, Wei JT, Chinnaiyan AM. Beyond PSA: the next generation of prostate cancer biomarkers. Science Translational Medicine. 4: 127rv3. PMID 22461644 DOI: 10.1126/scitranslmed.3003180  0.326
2011 Wang XS, Shankar S, Dhanasekaran SM, Ateeq B, Sasaki AT, Jing X, Robinson D, Cao Q, Prensner JR, Yocum AK, Wang R, Fries DF, Han B, Asangani IA, Cao X, et al. Characterization of KRAS rearrangements in metastatic prostate cancer. Cancer Discovery. 1: 35-43. PMID 22140652 DOI: 10.1158/2159-8274.Cd-10-0022  0.334
2011 Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discovery. 1: 391-407. PMID 22096659 DOI: 10.1158/2159-8290.CD-11-0209  0.461
2011 Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso CS, Kominsky HD, Cao X, Jing X, Wang X, Siddiqui J, Wei JT, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nature Biotechnology. 29: 742-9. PMID 21804560 DOI: 10.1038/nbt.1914  0.377
2011 Kim JH, Dhanasekaran SM, Prensner JR, Cao X, Robinson D, Kalyana-Sundaram S, Huang C, Shankar S, Jing X, Iyer M, Hu M, Sam L, Grasso C, Maher CA, Palanisamy N, et al. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Research. 21: 1028-41. PMID 21724842 DOI: 10.1101/Gr.119347.110  0.307
2010 Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, ... ... Prensner J, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 463: 899-905. PMID 20164920 DOI: 10.1038/Nature08822  0.552
2009 Wang XS, Prensner JR, Chen G, Cao Q, Han B, Dhanasekaran SM, Ponnala R, Cao X, Varambally S, Thomas DG, Giordano TJ, Beer DG, Palanisamy N, Sartor MA, Omenn GS, et al. An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer Nature Biotechnology. 27: 1005-1011. PMID 19881495 DOI: 10.1038/nbt.1584  0.463
2009 Prensner JR, Chinnaiyan AM. Oncogenic gene fusions in epithelial carcinomas. Current Opinion in Genetics & Development. 19: 82-91. PMID 19233641 DOI: 10.1016/j.gde.2008.11.008  0.355
2008 Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Research. 68: 73-80. PMID 18172298 DOI: 10.1158/0008-5472.CAN-07-5352  0.347
2007 Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, ... ... Prensner J, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences of the United States of America. 104: 20007-12. PMID 18077431 DOI: 10.1073/Pnas.0710052104  0.54
Show low-probability matches.